Loading…
Back To Schedule
Tuesday, June 26 • 8:00am - 9:15am
#213: 2018 Policy Mash-Up: New Shifts in the Healthcare Market and What They May Mean for Patients and the Biopharma Industry

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Component Type: Forum
Level: Intermediate
CE: ACPE 1.25 Knowledge UAN: 0286-0000-18-702-L04-P; CME 1.25; IACET 1.25; RN 1.25

The dynamics of the US healthcare market are shifting. Retailers are entering the world of healthcare in unorthodox ways; in one of the more prominent market shifts, we have seen a growing interest in consolidation between retail pharmacies and health plans. At the same time, Silicon Valley technology companies are looking to bring disruptive approaches to critical aspects of healthcare delivery. Shifts are also occurring on the public payer side; for example, new CMS policies will change the way states administer their Medicaid programs. How will all of these market changes impact biopharma innovators and patients? Come and hear from a range of experts about what’s triggering these market shifts, how they could affect care delivery, and what the future of healthcare may look like.

Learning Objectives

Recognize shifts in the healthcare market that may signal important changes in care delivery or access to treatments; Appraise the potential impact and how biopharmaceutical and device stakeholders might strategize to prepare for such changes.

Chair

Nancy Bradish Myers, Esq, JD

Speaker

Panelist
Larry Kocot, JD

Panelist
Darshak Sanghavi, MD

Panelist
Rick Weissenstein, MA


Speakers
LK

Larry Kocot

Principal, National Leader of the Center for Healthcare Regulatory Insight, KPMG
Larry Kocot is a Principal at KPMG, LLP and National Leader of KPMG’s Center for Healthcare Regulatory Insight. The Center follows health care regulatory and policy trends driving health care transformation and industry convergence and the broader implications of operating in a... Read More →
avatar for Nancy Myers

Nancy Myers

President and Founder, Catalyst Healthcare Consulting, Inc
Nancy Bradish Myers, JD is President/Founder of Catalyst Healthcare Consulting, a boutique regulatory advisory firm that helps innovators navigate FDA and policy circles. She served as a senior advisor in FDA's Office of the Commissioner and held senior positions at PhRMA, BIO and... Read More →
DS

Darshak Sanghavi

Chief Medical Officer and Senior Vice President of Translation, Optum Labs
RW

Rick Weissenstein

Managing Director, Health Care Services and Pharmaceutical Policy, Cowen Washington Research Group
Rick Weissenstein is part of the Cowen Washington Research Group and is responsible for analyzing health care policy issues and emerging trends in the federal and state legislative, regulatory, and legal arenas. He was formerly the Washington Bureau Chief for Modern Healthcare ma... Read More →

Tuesday June 26, 2018 8:00am - 9:15am EDT
Room 205AB Boston Convention and Exhibition Center 415 Summer Street, Boston, MA 02210 USA
  09: Regulatory, Forum